Ecotoxicol Environ Saf 207:111262
Are there any long-term health risks associated with Semaglutide
"These findings may inform shared decision making when considering GLP- 1 receptor agonist therapy and highlight the need for further evaluation of dermatological outcomes in future studies." The study involved a large number of people: 12,004 patients using GLP-1 drugs were compared to 15,221 using SGLT-2 inhibitors, with an additional 11,964 GLP-1 users compared to 11,233 using DPP-4 inhibitors
But this is something Phase 3 data needs to confirm more thoroughly
It is a selective agonist of ghrelin receptors, meaning it stimulates the release of growth hormone in a manner that closely mimics the natural physiological process
Persistent dark urine despite hydration, tea-coloured urine, or accompanying jaundice requires prompt medical evaluation to exclude gallbladder disease, hepatobiliary disorders, or acute kidney injury